MedTrace Logo

MGuard™ Prime Embolic Protection Stent in Patients With Acute ST Elevation Myocardial Infarction

NCT02292823 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 63

Last updated 2015-09-02

No results posted yet for this study

Summary

Prospective, non-randomized, single arm, multicenter observational study. The objective is to evaluate the safety and efficacy of the MGuard™ Prime stent in the treatment of de novo stenotic lesions in coronary arteries in patients undergoing primary percutaneous coronary intervention (PCI) due to acute ST elevation myocardial infarction (STEMI) in a real-world setting.

Conditions

  • ST Elevation Myocardial Infarction

Interventions

DEVICE

MGuard™ Prime Embolic Protection Stent System

Sponsors & Collaborators

  • InspireMD

    lead INDUSTRY

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-04-30
Primary Completion
2015-09-30
Completion
2016-09-30

Countries

  • Netherlands

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02292823 on ClinicalTrials.gov